Max Robotics — Global Service Robot Directory + US Certification

About

Fabian Siegel is a pioneering urological surgeon and clinical researcher whose work sits at the intersection of robotic surgery, evidence-based medicine, and digital health communication. His primary research areas include robotic-assisted partial nephrectomy, lymphocele prevention following radical prostatectomy, and the analysis of public health information on new media platforms. Siegel is best known for leading the ROBOCOP II trial—the first randomized controlled feasibility study comparing robot-assisted versus open partial nephrectomy—and the PELYCAN trial, a phase 3 RCT demonstrating that a peritoneal flap significantly reduces symptomatic lymphoceles after robotic prostatectomy with lymph node dissection. His work has garnered over 80 citations, with the ROBOCOP II study alone cited 39 times. Beyond the operating room, Siegel has pioneered novel methodologies to quantify public versus academic interest in urology, systematically analyzing YouTube content to expose the prevalence of misinformation about radical prostatectomy. His dual commitment to rigorous surgical trials and patient education positions him as a leader shaping both the technical and communicative future of urology.